 | • レポートコード：MRC2-11QY02723 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は水虫薬のグローバル市場について調査・分析したレポートです。種類別（クリーム、スプレー、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別水虫薬の競争状況、市場シェア ・世界の水虫薬市場：種類別市場規模 2015年-2020年（クリーム、スプレー、その他） ・世界の水虫薬市場：種類別市場規模予測 2021年-2026年（クリーム、スプレー、その他） ・世界の水虫薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の水虫薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の水虫薬市場分析：米国、カナダ ・ヨーロッパの水虫薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの水虫薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の水虫薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの水虫薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、GSK、Janssen Pharmaceutica NV ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Athlete’s foot, known medically as tinea pedis, is a common skin infection of the feet caused by fungus.Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete’s foot fungus may infect any part of the foot, but most often grows between the toes.The next most common area is the bottom of the foot.The same fungus may also affect the nails or the hands.It is a member of the group of diseases known as tinea.
Market Analysis and Insights: Global Athlete’s Foot Drugs Market
The global Athlete’s Foot Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Athlete’s Foot Drugs Scope and Market Size
Athlete’s Foot Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Athlete’s Foot Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Athlete’s Foot Drugs market is segmented into
Cream
Spray
Other
Segment by Application, the Athlete’s Foot Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Athlete’s Foot Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Athlete’s Foot Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Athlete’s Foot Drugs Market Share Analysis
Athlete’s Foot Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Athlete’s Foot Drugs business, the date to enter into the Athlete’s Foot Drugs market, Athlete’s Foot Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
GSK
Janssen Pharmaceutica NV
…
1 Study Coverage
1.1 Athlete’s Foot Drugs Product Introduction
1.2 Market Segments
1.3 Key Athlete’s Foot Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Athlete’s Foot Drugs Market Size Growth Rate by Type
1.4.2 Cream
1.4.3 Spray
1.4.4 Other
1.5 Market by Application
1.5.1 Global Athlete’s Foot Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Athlete’s Foot Drugs Market Size, Estimates and Forecasts
2.1.1 Global Athlete’s Foot Drugs Revenue 2015-2026
2.1.2 Global Athlete’s Foot Drugs Sales 2015-2026
2.2 Global Athlete’s Foot Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Athlete’s Foot Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Athlete’s Foot Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Athlete’s Foot Drugs Competitor Landscape by Players
3.1 Athlete’s Foot Drugs Sales by Manufacturers
3.1.1 Athlete’s Foot Drugs Sales by Manufacturers (2015-2020)
3.1.2 Athlete’s Foot Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Athlete’s Foot Drugs Revenue by Manufacturers
3.2.1 Athlete’s Foot Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Athlete’s Foot Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Athlete’s Foot Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Athlete’s Foot Drugs Revenue in 2019
3.2.5 Global Athlete’s Foot Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Athlete’s Foot Drugs Price by Manufacturers
3.4 Athlete’s Foot Drugs Manufacturing Base Distribution, Product Types
3.4.1 Athlete’s Foot Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Athlete’s Foot Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Athlete’s Foot Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Athlete’s Foot Drugs Market Size by Type (2015-2020)
4.1.1 Global Athlete’s Foot Drugs Sales by Type (2015-2020)
4.1.2 Global Athlete’s Foot Drugs Revenue by Type (2015-2020)
4.1.3 Athlete’s Foot Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Athlete’s Foot Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Athlete’s Foot Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Athlete’s Foot Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Athlete’s Foot Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Athlete’s Foot Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Athlete’s Foot Drugs Market Size by Application (2015-2020)
5.1.1 Global Athlete’s Foot Drugs Sales by Application (2015-2020)
5.1.2 Global Athlete’s Foot Drugs Revenue by Application (2015-2020)
5.1.3 Athlete’s Foot Drugs Price by Application (2015-2020)
5.2 Athlete’s Foot Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Athlete’s Foot Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Athlete’s Foot Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Athlete’s Foot Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Athlete’s Foot Drugs by Country
6.1.1 North America Athlete’s Foot Drugs Sales by Country
6.1.2 North America Athlete’s Foot Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Athlete’s Foot Drugs Market Facts & Figures by Type
6.3 North America Athlete’s Foot Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Athlete’s Foot Drugs by Country
7.1.1 Europe Athlete’s Foot Drugs Sales by Country
7.1.2 Europe Athlete’s Foot Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Athlete’s Foot Drugs Market Facts & Figures by Type
7.3 Europe Athlete’s Foot Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Athlete’s Foot Drugs by Region
8.1.1 Asia Pacific Athlete’s Foot Drugs Sales by Region
8.1.2 Asia Pacific Athlete’s Foot Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Athlete’s Foot Drugs Market Facts & Figures by Type
8.3 Asia Pacific Athlete’s Foot Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Athlete’s Foot Drugs by Country
9.1.1 Latin America Athlete’s Foot Drugs Sales by Country
9.1.2 Latin America Athlete’s Foot Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Athlete’s Foot Drugs Market Facts & Figures by Type
9.3 Central & South America Athlete’s Foot Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Athlete’s Foot Drugs by Country
10.1.1 Middle East and Africa Athlete’s Foot Drugs Sales by Country
10.1.2 Middle East and Africa Athlete’s Foot Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Athlete’s Foot Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Athlete’s Foot Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Athlete’s Foot Drugs Products Offered
11.1.5 Bayer Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description and Business Overview
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Athlete’s Foot Drugs Products Offered
11.2.5 GSK Related Developments
11.3 Janssen Pharmaceutica NV
11.3.1 Janssen Pharmaceutica NV Corporation Information
11.3.2 Janssen Pharmaceutica NV Description and Business Overview
11.3.3 Janssen Pharmaceutica NV Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Janssen Pharmaceutica NV Athlete’s Foot Drugs Products Offered
11.3.5 Janssen Pharmaceutica NV Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Athlete’s Foot Drugs Products Offered
11.1.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Athlete’s Foot Drugs Market Estimates and Projections by Region
12.1.1 Global Athlete’s Foot Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Athlete’s Foot Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Athlete’s Foot Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Athlete’s Foot Drugs Sales Forecast (2021-2026)
12.2.2 North America: Athlete’s Foot Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Athlete’s Foot Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Athlete’s Foot Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Athlete’s Foot Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Athlete’s Foot Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Athlete’s Foot Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Athlete’s Foot Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Athlete’s Foot Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Athlete’s Foot Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Athlete’s Foot Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Athlete’s Foot Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Athlete’s Foot Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Athlete’s Foot Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Athlete’s Foot Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Athlete’s Foot Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Athlete’s Foot Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Athlete’s Foot Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Athlete’s Foot Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Athlete’s Foot Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Athlete’s Foot Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Athlete's Foot Drugs Market Segments
Table 2. Ranking of Global Top Athlete's Foot Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Athlete's Foot Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cream
Table 5. Major Manufacturers of Spray
Table 6. Major Manufacturers of Other
Table 7. Global Athlete's Foot Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Athlete's Foot Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Athlete's Foot Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Athlete's Foot Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Athlete's Foot Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Athlete's Foot Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Athlete's Foot Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Athlete's Foot Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Athlete's Foot Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Athlete's Foot Drugs as of 2019)
Table 16. Athlete's Foot Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Athlete's Foot Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Athlete's Foot Drugs Price (2015-2020) (USD/Unit)
Table 19. Athlete's Foot Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Athlete's Foot Drugs Product Type
Table 21. Date of International Manufacturers Enter into Athlete's Foot Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Athlete's Foot Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Athlete's Foot Drugs Sales Share by Type (2015-2020)
Table 25. Global Athlete's Foot Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Athlete's Foot Drugs Revenue Share by Type (2015-2020)
Table 27. Athlete's Foot Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Athlete's Foot Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Athlete's Foot Drugs Sales Share by Application (2015-2020)
Table 30. North America Athlete's Foot Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Athlete's Foot Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Athlete's Foot Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Athlete's Foot Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Athlete's Foot Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Athlete's Foot Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Athlete's Foot Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Athlete's Foot Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Athlete's Foot Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Athlete's Foot Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Athlete's Foot Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Athlete's Foot Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Athlete's Foot Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Athlete's Foot Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Athlete's Foot Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Athlete's Foot Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Athlete's Foot Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Athlete's Foot Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Athlete's Foot Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Athlete's Foot Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Athlete's Foot Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Athlete's Foot Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Athlete's Foot Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Athlete's Foot Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Athlete's Foot Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Athlete's Foot Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Athlete's Foot Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Athlete's Foot Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Athlete's Foot Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Athlete's Foot Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Athlete's Foot Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Athlete's Foot Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Athlete's Foot Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Athlete's Foot Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Athlete's Foot Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Athlete's Foot Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Athlete's Foot Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Athlete's Foot Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Athlete's Foot Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Athlete's Foot Drugs Sales Market Share by Application (2015-2020)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Major Businesses
Table 72. Bayer Athlete's Foot Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Bayer Product
Table 74. Bayer Recent Development
Table 75. GSK Corporation Information
Table 76. GSK Description and Major Businesses
Table 77. GSK Athlete's Foot Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK Product
Table 79. GSK Recent Development
Table 80. Janssen Pharmaceutica NV Corporation Information
Table 81. Janssen Pharmaceutica NV Description and Major Businesses
Table 82. Janssen Pharmaceutica NV Athlete's Foot Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Janssen Pharmaceutica NV Product
Table 84. Janssen Pharmaceutica NV Recent Development
Table 85. Global Athlete's Foot Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 86. Global Athlete's Foot Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 87. Global Athlete's Foot Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 88. Global Athlete's Foot Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 89. North America: Athlete's Foot Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 90. North America: Athlete's Foot Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 91. Europe: Athlete's Foot Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 92. Europe: Athlete's Foot Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Asia Pacific: Athlete's Foot Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 94. Asia Pacific: Athlete's Foot Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 95. Latin America: Athlete's Foot Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 96. Latin America: Athlete's Foot Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Middle East and Africa: Athlete's Foot Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 98. Middle East and Africa: Athlete's Foot Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 100. Key Challenges
Table 101. Market Risks
Table 102. Main Points Interviewed from Key Athlete's Foot Drugs Players
Table 103. Athlete's Foot Drugs Customers List
Table 104. Athlete's Foot Drugs Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Athlete's Foot Drugs Product Picture
Figure 2. Global Athlete's Foot Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Cream Product Picture
Figure 4. Spray Product Picture
Figure 5. Other Product Picture
Figure 6. Global Athlete's Foot Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Pharmacy
Figure 10. Athlete's Foot Drugs Report Years Considered
Figure 11. Global Athlete's Foot Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Athlete's Foot Drugs Sales 2015-2026 (K Units)
Figure 13. Global Athlete's Foot Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Athlete's Foot Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Athlete's Foot Drugs Sales Market Share by Region in 2019
Figure 16. Global Athlete's Foot Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Athlete's Foot Drugs Revenue Market Share by Region in 2019
Figure 18. Global Athlete's Foot Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Athlete's Foot Drugs Revenue in 2019
Figure 20. Athlete's Foot Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Athlete's Foot Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Athlete's Foot Drugs Sales Market Share by Type in 2019
Figure 23. Global Athlete's Foot Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Athlete's Foot Drugs Revenue Market Share by Type in 2019
Figure 25. Global Athlete's Foot Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Athlete's Foot Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Athlete's Foot Drugs Sales Market Share by Application in 2019
Figure 28. Global Athlete's Foot Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Athlete's Foot Drugs Revenue Market Share by Application in 2019
Figure 30. North America Athlete's Foot Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Athlete's Foot Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Athlete's Foot Drugs Sales Market Share by Country in 2019
Figure 33. North America Athlete's Foot Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Athlete's Foot Drugs Market Share by Type in 2019
Figure 39. North America Athlete's Foot Drugs Market Share by Application in 2019
Figure 40. Europe Athlete's Foot Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Athlete's Foot Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Athlete's Foot Drugs Sales Market Share by Country in 2019
Figure 43. Europe Athlete's Foot Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Athlete's Foot Drugs Market Share by Type in 2019
Figure 55. Europe Athlete's Foot Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Athlete's Foot Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Athlete's Foot Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Athlete's Foot Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Athlete's Foot Drugs Revenue Market Share by Region in 2019
Figure 60. China Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Athlete's Foot Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Athlete's Foot Drugs Market Share by Application in 2019
Figure 84. Latin America Athlete's Foot Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Athlete's Foot Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Athlete's Foot Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Athlete's Foot Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Athlete's Foot Drugs Market Share by Type in 2019
Figure 95. Latin America Athlete's Foot Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Athlete's Foot Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Athlete's Foot Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Athlete's Foot Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Athlete's Foot Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Athlete's Foot Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Athlete's Foot Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Athlete's Foot Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Athlete's Foot Drugs Market Share by Application in 2019
Figure 108. North America Athlete's Foot Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Athlete's Foot Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Athlete's Foot Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Athlete's Foot Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Athlete's Foot Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Athlete's Foot Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Athlete's Foot Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Athlete's Foot Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Athlete's Foot Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Athlete's Foot Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…- 糖尿病性足潰瘍治療薬の世界市場（～2026年） Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing br…
- フットケア薬用クリームの世界市場（～2026年） Market Analysis and Insights: Global Foot Care Medicated Creams Market The global Foot Care Medicated Creams market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Foot Care Medicated Creams Scope and Market Size Foot Care Me…
- 糖尿病性足潰瘍・褥瘡の世界市場（～2026年） Diabetic foot ulcers, are most common chronic wounds in patients suffering from diabetes, and lack of proper treatment of the foot ulcers often lead to progression of the wound resulting in lower extremity / foot amputation. Pressure ulcers are often a cause of lack of movement of the patients, long…
- フットスパバスの世界市場（～2026年） Market Analysis and Insights: Global Foot Spa Bath Market The global Foot Spa Bath market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Foot Spa Bath Scope and Market Size Foot Spa Bath market is segmented by Type, and by A…